Objective To evaluate the association between increased exposure to airborne fine particulate matter (PM2.5) during the periconception period with risk of congenital anomalies.
1
The spectrum of birth defects is wide, ranging from minor anomalies having no adverse health effects to severe major malformations that result in death. As a group, congenital anomalies are a leading cause of infant mortality in the US. 1 Although some specific malformations have a clear cause-effect relationship with periconception exposure such as poor glycemic control in diabetics and the caudal regression syndrome or thalidomide and limb reduction anomalies, most congenital anomalies have no known singular teratogenic etiology. 2 Considering that embryonic maldevelopment leading to congenital anomalies is a multifactorial disease process, investigators have become increasingly interested in the contribution of modifiable risk factors such as exposure to environmental pollutants. Prior studies that have indicated the possible association of particulate matter (PM) with birth defects, have been limited by inconsistency in definitions of high exposure levels, geographic measures of exposure, and timing of high exposure assignment. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Inconsistent definitions of high exposure levels not only lead to inconsistent findings, but also introduce bias into the estimates of ORs by improperly dichotomizing PM2.5 exposure. 13 The majority of prior studies on PM exposure examined coarse particles (aerodynamic diameter of ≤10 µg/m 3 [PM10]), which can be inhaled and accumulate in the respiratory system. Fine particles, PM2.5 (aerodynamic diameter of <2.5 µg/m 3 ) are believed to be a more significant health hazard because they can deposit deep into lower airways and alveoli within the lungs, and subsequently enter the systemic circulation. 14 However, findings from studies examining PM2.5 on congenital anomaly risk have been inconsistent showing minor associations with a few individual anomalies or no effect. 3, 6, 7, [10] [11] [12] 15 Because embryonic development occurs in the first trimester of pregnancy, the timing between an exposure and maldevelopment, assuming a true cause-effect relationship, must occur either before conception or in the early first trimester of pregnancy. Prior studies of PM2.5 have limited the exposure period studied to a small window during the early first trimester only, and did not investigate PM2.5 Particular matter QIC Quasi-Akaike information criterion exposure in the months preceding conception. 3, 6, 7, 10, 11, 15 In this study, we aim to describe the association between exposure to airborne fine particle pollution, PM2.5, in a month-by-month fashion examining the time extending from 2 months before and through 2 months after conception with risk of congenital malformations. We also explore exposure-outcome associations by varying the cutoff values of geographic distance from monitoring station.
Methods
We developed a geospatial, population-based cohort study using Ohio Department of Health live birth records. The Ohio Department of Health and Human Subjects Institutional Review Board approved a protocol for this study. This study was exempt from review by the Institutional Review Board at the University of Cincinnati, Cincinnati, Ohio. A dataset generated from vital records of all live births that occurred in the state from 2006 to 2010 was provided for this analysis. We analyzed live births to women whose residential address was within a defined distance threshold of their nearest PM2.5 monitor. A detailed description of the study population is illustrated in Figure 1 .
Births with recorded Down syndrome or other suspected chromosomal disorder (pending or confirmed) 16, 17 were not included in the primary analysis; however, they were examined as individual outcomes and also included in a separate sensitivity analysis.
Exposure values from central monitoring stations were used to estimate personal exposure levels of births during the study period. As there has been no clearly defined optimal distance cutoff to estimate exposure values related to a stationary monitor, we analyzed outcomes using multiple distances including residential address perimeters of 5, 7, and 10 km from monitoring station. 6, 8, 16, 18, 19 PM2.5 Exposure Assessment PM2.5 levels were measured daily during the study period (2005-2010) by 57 US Environmental Protection Agency stationary monitors across Ohio, and from this monthly averages were calculated. 20 The monthly averages were linked to Ohio birth records using the location of maternal residences. 21 We assigned the monthly average values of PM2.5 to each birth for 5 different monthly time periods: 1 and 2 months before and after conception, and the month of conception, linking data from the nearest monitoring stations using ArcGIS 10. Birth weight <350 g (n = 366), Birth weight >6000 g (n = 183) Missing gestational age data, gestational age >42 weeks, gestational age <20 weeks (n = 2779)
Total births eligible for PM2.5 analysis: (n = 548 863)
Replicates in multiple gestation (n = 12 866)
Missing data on maternal race, education, or prepregnancy diabetes (n = 14 582) Figure 1 . Flow diagram of the study population.
Volume 193 • February 2018 ware (ESRI, Redlands, Calif). These periconception time periods were calculated based on the gestational age at birth recorded in the birth certificate. There is no standard for the definition of "high exposure" in studies using stationary monitor exposure data for birth outcome. 16 Dichotomizing exposure values may be problematic and may introduce bias into the estimates of ORs. 13 Therefore, in our study, we treated PM2.5 exposure as a continuous variable, and reported ORs in both per IQR and per 10 µg/m 3 increase. The primary outcome was major congenital anomaly at birth, as recorded on the 2003 version of the US birth certificate. Congenital anomaly of a newborn is recorded in the US standard certificate of live birth in a standardized manner. Strict criteria for the definition of each congenital anomaly are outlined in the Guide to Completing The Facility Worksheets for the Certificate of Live Birth and Report of Fetal Death (2003 revision), from the National Center for Health Statistics. 22 The presence of a major congenital anomaly in this study was defined as the presence of 1 or more of those reported anomalies. The frequency of the primary outcome of any congenital anomaly and the secondary outcomes of individual congenital anomalies were calculated.
Statistical Analyses
The frequency of individual congenital anomalies recorded on the live birth certificate within the defined areas of study, stratified by distance cutoff from monitor (5, 7, and 10 km) were calculated. Baseline maternal and delivery characteristics were compared between the outcome group with congenital anomalies and the referent group of births with no anomaly, with P value reported for c 2 test comparisons for the 10-km cutoff dataset (n = 289 950). Rates of congenital anomalies among each baseline characteristic are reported as number of anomaly cases per 1000 live births. Summary statistics of PM2.5 levels were then calculated for births with congenital anomalies and those with no anomalies, stratified by month of exposure. No adjustment for multiple comparisons is preferable in this type of observational study because it leads to fewer errors of interpretation and allows for detection of natural observations of association. 23 We used binomial regression with logistic link to analyze the association between congenital anomalies and PM2.5 exposures. Considering the spatial correlation of subjects sharing the same monitoring station, the use of a marginal model for this study is suitable. We used generalized estimating equations with an exchangeable correlation structure to account for spatial correlation of subjects sharing the same PM2.5 monitor. 24 Estimates of association were adjusted for the confounding effects of maternal and newborn factors. After model selection criteria described elsewhere in this article, some of those individual covariates were removed from the final adjusted model.
To assess the influence of time of PM2.5 exposure on the primary outcome of any congenital anomaly, we stratified the exposure-outcome adjusted analyses by multiple time periods during the periconception period: 1 and 2 months before and after conception, the month of conception, and the average of 3 periconception months. To provide a more comprehensive description of the influence of PM 2.5 exposure on specific organ systems, analyses were repeated for the secondary outcomes of individual anomalies grouped by organ systems. Results are reported as aOR with 95% CI. Displaying the association as ORs with CI provides more information with regard to the direction of effect and effect size compared with just presenting association with P values, and also avoids the need of complicated multiple testing adjustment methods for the P values, because they are highly correlated. 25 The following rules were considered in model selection. (1) Biological plausibility: Based on previously published data 8, 11, 26 as well as known factors associated with congenital anomalies, we included some covariates in our adjusted models based on their biological plausibility, rather than selection by small P value or "best" fit under a model selection rule. Such variables included maternal age, race, smoking status, season of conception, and prepregnancy diabetes. (2) Quasi-Akaike information criterion (QIC): The QIC is a model fitting criteria for generalized linear models using generalized estimating equations. 27 Models with lower QIC values were favored as they represent better model fit. (3) Covariate set selection for consistent adjustment in multiple analyses. Owing to the varying quantity of missing data or observations in the multiple stratified analysis using different distance cutoffs and time periods of exposure, a single consistent set of covariates was chosen for all adjusted analyses rather than model-specific covariate sets selected for each individual analysis.
Final models were constructed incorporating a group of covariates selected based on biological plausibility and low QIC. The final models included the following covariates: maternal age (coded as categorical variables with 3 levels: less than 18, 19-34, and greater than 34 years of age), 14 race/ethnicity (Hispanic, non-Hispanic white, non-Hispanic black, and nonHispanic others), prepregnancy diabetes, smoking status, marital status, educational level (coded as categorical variables with 3 levels: less than high school, high school graduate, and postsecondary education), season of conception, and infant sex.
We performed sensitivity analyses modeling smoking in pregnancy as average number of cigarette smoked during the immediate preconception period as a categorical variable composed of 4 groups: non-smokers, 1-9 cigarettes per day, 10-19 cigarettes per day, and more than 20 cigarettes smoked per day. In addition, we performed sensitivity analyses measuring the association between the PM2.5 and congenital anomalies by including and excluding genetic abnormalities in the outcome analyses.
Results
The locations of congenital anomaly cases, PM2. the most densely populated counties have the highest number of congenital anomalies cases ( Figure 3, A) ; however, they have a relatively low frequency of congenital anomalies based on high birth density within the county (Figure 3, B) . Likewise, some counties with low birth density have higher rates of congenital anomalies.
The frequency of congenital anomalies that occurred within the 3 specified distance cutoffs are presented in Table I (available at www.jpeds.com). The most common anomaly was cleft lip/palate, followed by abdominal wall defects. Differences in maternal demographic and pregnancy characteristics between the outcome group with congenital anomalies and the referent group of births with no anomaly are presented in Table II (available at www.jpeds.com). Births complicated by congenital anomalies occurred more commonly in young mothers 18 years of age or younger, non-Hispanic white mothers, those with low educational attainment, and those of low socioeconomic status (as measured by use of Medicaid insurance). Cigarette smoking and prepregnancy diabetes were also significantly associated with presence of congenital anomalies. The rate of congenital anomalies was highest among pregnancies complicated by pregestational diabetes, at 7.1 cases per 1000 live births. Anomalies occurred slightly more frequently in the earlier years of study (2006 and 2007) , and in births during the summer and fall seasons. The mean PM2.5 level during the periconception period for the study population was 13.79 µg/m 3 among the 10-km cohort, which was slightly lower than Environmental Protection Agency standard during the study period of 15 µg/m tal anomaly had a higher mean PM2.5 exposure level compared with nonanomalous births across all periconception months and within each distance cohort. Table III demonstrates the mean PM2.5 levels in pregnancies complicated by congenital anomalies compared with births with no anomaly, stratified by periconception month of exposure and distance from the monitoring station.
The association between PM2.5 exposure and congenital anomalies during each periconception period is displayed in Table IV as adjusted ORs with 95% CI for each distance cutoff ); Q1/Q3, lower/upper quartile. *Local PM2.5 level for each subject is assigned by the nearest monitoring station during that time period. This table shows the summary statistics of population average of local PM2.5 using this assignment (estimation) method.
†Average of 3 months = 2 months before conception, 1 month before conception, and the month of conception. ‡P values were calculated using the 2-sample t test. Table IV allows for examination of consistency or inconsistency of findings based on distance from the monitoring station exposure assessment. Of all the time periods and distance cutoffs under investigation, nearly all point estimates of effect demonstrate an OR of greater than 1. However, only several of the associations reached statistical significance with lower limit of the 95% CI of greater than 1. These modeling results are also consistent with the unadjusted comparisons shown in Table III .
We found that increasing PM2.5 exposure levels occurring 1 month before conception consistently demonstrated the highest aOR point estimates and corresponding 95% CI lower bounds among all 3 preconception time windows from the 10-km model to the 5-km model. In addition, this finding shown in Table IV is consistent with unadjusted descriptive results in Table III , which implies that this association cannot be explained by factors adjusted in the models. Therefore, these results suggest that compared with other preconception periods, increasing PM2.5 exposure during the 1 month before conception is more likely to be associated with increasing risk of congenital anomalies.
We also assessed the inconsistency of results between the 3 distance cutoff models shown in Table IV . First, increasing PM2.5 exposure 1 month after conception exposure was significantly associated with congenital anomalies in the 10-km and 7-km models, but not in the smaller 5-km model. Second, the association between PM2.5 exposure 1 month before conception is only significant at 5% significance level for the 5-km model; however, this association became stronger with smaller distance cutoffs from the 10-km cohort to the 5-km cohort (Tables III and IV ). Our findings demonstrate some evidence of spatial variability of PM2.5 exposure within the 10-km cutoff, considering some inconsistency of results compared with more narrow distance cutoff cohorts. Tables V, VI , and VII (available at www.jpeds.com) demonstrate the association of PM2.5 exposure with individual anomalies, grouped by organ system. 16 Considering the small number of cases for each individual anomaly, the CIs shown in these tables are comparatively wider than those in Table IV among each distance cutoff. The small sample size in these individual comparisons limits the ability to draw significant conclusions from these analyses. However, stratifying the analyses by individual anomalies in an exploratory manner does highlight several specific organ systems associated with PM2.5, such as urogenital and gastrointestinal organ systems, which may be useful for hypothesis generation and validation in larger analyses. The interpretation of modeling results for anomalies with a small number of cases may also be limited owing to model overfitting, if considering a general practice of having at least 10 cases per 1 covariate variable. Overfitting with a high ratio of covariates to cases may lead to less reliable risk estimates and exaggerated CIs. For anomalies with a larger number of cases, such as abdominal defects, neural tube defects, and cleft lip or cleft palate, the results should be more reliable.
Secondary Outcomes: Individual Congenital Anomalies
The primary adjusted models presented in this study used the covariate cigarette smoking as a dichotomous yes/no (1, 0) variable. In sensitivity analyses, we modeled average number of cigarettes smoked per day as a categorical covariate rather than dichotomous, which resulted in findings consistent with our initial results ( Table IV) . We also performed sensitivity analyses considering the influence of genetic disorders.
Most prior published studies examining the association of PM2.5 with congenital anomalies excluded cases of chromosome disorders. Considering the possibility that chromosome disorders could be on the causal pathway of PM2.5 exposure and congenital anomalies, we performed sensitivity analysis including and excluding live births with chromosome disorders as recorded on the US birth certificate for the study population. The primary results excluding chromosome disorders are displayed in Table IV, as described previously. For sensitivity analyses, first we examined the association of births complicated by chromosome disorders (Down syndrome or other, karyotype confirmed or pending) with PM2.5 exposure. This initial sensitivity analysis included only cases with chromosome disorders, in the absence of other congenital anomalies. As shown in Tables V-VII, we found no risk increase of chromosome disorders with PM2.5 exposure. Then, we analyzed the association between PM2.5 and congenital anomalies including cases with chromosome disorders. We found that, after including the chromosome disorder subjects in the analysis, no risk increases were observed at any periconception periods (data not shown). However, the trends persisted, with higher point estimate and 95% CI lower bounds at 1 month before conception than other periconception time periods. Given the lack of a significant association between PM2.5 and chromosome disorders demonstrated in these analyses, we prefer to model the analyses excluding births complicated by chromosome disorders (results as demonstrated in Table IV ).
Discussion
We found that exposure to increasing levels of PM2.5 in the air during some critical periods during the periconception period may be associated with a modest increased risk of a major congenital anomaly, even after adjustment for confounding influences of other factors associated with malformation risk. The association with PM2.5 exposure during the other time periods, either earlier or later, was nonsignificant, suggesting the times nearest to conception may be the most susceptible time of exposure for this risk. Our analysis adds depth and clarity to the current body of evidence investigating the possible association between air pollutants and the risk of birth defects. We provide novel data by exploring a detailed monthby-month exposure risk assessment, including the months before conception, to assess if there is a particularly ORIGINAL ARTICLES susceptible time in the periconception period when exposure to airborne PM may pose a hazard to development of fetal anomalies. The time of embryonic development, weeks 3-10 of gestational age or weeks 1-8 of embryonic age, are thought to be the critical times of exposure for most teratogenic agents to risk of birth defects. This window would indeed be the most critical time if the exposure were known to have a deleterious embryonic effect with only acute high-level exposure. However, the association between air pollutants and adverse health outcomes may not be a clear immediate temporal exposure-outcome relationship. Buildup or accumulation of high concentrations of some pollutants or their metabolites over a longer period of time may pose a more notable risk for congenital anomalies if the high-level exposure occurs during the preconception period.
29 Long-term high PM2.5 exposure specifically has been shown to cause oxidative stress, inflammation, and mitochondrial alteration, 30 and to have a higher risk of deleterious health effects. 31 Therefore, exposure to increased amounts of air pollutants may also affect birth defect risk in the time period preceding pregnancy, rather than only during the first trimester (weeks 1-12 of gestation). Prior studies examining the association between PM2.5 and birth defects have only measured this relationship during a brief period of exposure in the first trimester only, and did not measure PM2.5 exposure in the months preceding conception. 3, 6, 7, [10] [11] [12] 15 In the present study, we aimed to assess the specific time of exposure in the periconception period when increased pollutant exposure may be the most deleterious, by examining exposure timing of exposure in a month-by-month fashion extending from 2 months before to 2 months after conception.
In this study, we report the association of PM2.5 exposure with any anomaly, as recorded in the US birth certificate, and also with individual malformations and malformations grouped by organ systems involved. We found a modest but positive association with increasing levels of PM2.5 exposure 1 month before and 1 month after conception with risk of any congenital anomaly, when assessed as a composite variable. Additionally, we found some risk increases among individual anomalies limited to cases of hypospadias and abdominal defects, which had not been reported previously as individual outcomes associated with PM2.5 exposure. 3, 6, 7, [10] [11] [12] 15 A review of ambient air pollution and risk of congenital anomalies highlighted the narrow focus of the number of birth defects included in prior studies. The authors suggested future studies should focus on anomalies other than just cardiac and facial clefts, have clear definitions of case classification, and use of classifications and exclusions in sensitivity analyses. 16 Few studies included the spectrum of all reported anomalies, 11, 17, 18 and most looked only at cardiac anomalies. 5, 6, 10, 19 Some studies have also suggested that air pollutant exposure may be associated with increased risk of common fetal chromosome abnormalities, such as trisomy 21 and Down syndrome. 32 Inclusion and exclusion of chromosomal, syndromic, and multiple anomalies have differed between studies, 16 contributing to significant study heterogeneity and limiting the generalizability of the findings. To assess whether chromosome abnormalities may be in the causal pathway of PM 2.5 exposure to birth defect risk, we measured the association with anomalies both including and excluding cases of chromosome disorders. We further analyzed the association between PM2.5 and chromosome disorders, with congenital anomaly cases excluded. We found no association between PM2.5 exposure and risk of fetal chromosome abnormalities, regardless of the periconception timing of exposure. Additionally, the risk of anomalies was not detectable with the inclusion of cases with concomitant chromosome disorders. Based on these findings, we feel that the preferable approach to assess PM-birth defect risk is to limit the analysis to congenital anomalies without concurrent chromosome disorders.
Although the use of stationary monitors to assign individuallevel exposures within a specified radius surrounding the monitor has obvious limitations, it has been widely used for measurement in prior air particulate-birth outcome assessment studies. Using this approach, measurement error owing to spatial variability may lead to erroneous negative results, often biasing the risk estimates toward the null. 33 Studies including a large perimeter around a PM monitor for exposure quantification and also reporting a null association with birth defects have been a common theme in previously published studies on this topic. However, limiting analyses to narrow distance cutoffs decreases sample size. Given the low frequency of congenital anomalies in the population (3%-8%), 1 investigators must balance the tradeoff between sample size and accuracy of exposure assessment when choosing the best cutoff for their studies. Of the prior published studies on PM and birth defects, reported distances from maternal residence to stationary monitors have varied greatly, with some not reporting the distance, 4, 9, 34 to others reporting distances of 10 km, 18 16 km, 8 40 km, 6 or even a maximum distance as far as 50-80 km from a monitor. 10, 19 The large population-based cohort included in our study allowed us to model several relatively narrow distance cutoffs and compare their findings among air exposure-outcome assessment for birth defects. We found that the use of various distance cutoffs, including the commonly used 10-km distance, compared with more narrow areas with 7-and 5-km cutoffs provided some advantages and disadvantages. The consistency and inconsistency of results identified in the 3 exposure measurement distance cutoffs presented here are likely related to spatial heterogeneity within the larger distances and more precise exposure quantification but smaller sample size and power when using a smaller distance as a cutoff. An additional contributor to variation and inconsistency of results is that the location of exposure identified by maternal residential address does not account for women who moved during the pregnancy. Likewise, it also does not account for exposure at nonresidential addresses, such as work or school, which may be outside of the 10-km radius of the recorded home address.
An additional challenge in the interpretation of results from prior studies is the variability in the methods used to define high levels of PM exposure. A variety of exposure quantification strategies have been used modeling PM levels in the air as a continuous variable, or defining high PM exposure in a dichotomous approach considering the upper quantile or THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 193 greater than mean plus IQR as "high." Still others quantified high exposure as per unit increases or per quantile increases associated with risk of congenital anomalies. These variations in measurement of exposure, analytic strategy, and reporting of results make it quite challenging to interpret the results into a way that has practical generalizability. 16 Dichotomizing exposure values may be problematic and may introduce bias into the estimates of ORs. 13 Therefore, in this study, we provide data from an analytic approach using a continuous model of exposure assessment in an attempt to provide the most informative and nonbiased results.
There are a number of inherent limitations to this type of study aimed to measure the association between airborne PM exposure and birth defect risk. However, by using multiple methodologic approaches, we feel we provide an important breadth of data on the optimal exposure ascertainment, measurement, and design characteristics that contribute to the reliability of the associations we have identified regarding PM2.5 exposure and risk of congenital malformations. The overall rate of anomalies reported in this study is lower than the known population prevalence. Birth certificate records have a lower sensitivity for identifying birth defects compared with review of medical records, as not all birth defects are readily identifiable within the first few days of birth when the birth certificate is generated. Therefore, some congenital anomalies that are not yet identified may be coded as no anomaly in the birth certificate, biasing the results of our study and those of many similar in design toward the null. Alternatively, some birth defects recorded on the birth certificate may not be documented accurately, which could lead to some misclassification of case or referent group status. Additionally, some defects are recorded within a category by organ system and do not provide data on the specific malformation, which limits the ability to assess individual malformation exposure risks, such as in the category of congenital heart defects.
The mechanism of teratogenicity for airborne pollutant exposures are generally speculative. 16 Some hypothesized mechanisms include oxidative stress, coagulation aberrations, and placental inflammation. 35 These mechanisms could affect embryogenesis by influencing the migration and differentiation of neural crest cells. Additionally, some pollutants have demonstrated embryotoxicity in animal models. 16 Future investigations should build on the knowledge gained from this study and use approaches aimed to optimize scientific rigor, minimize bias, and report the most accurate assessment of risk for air pollutants and development of congenital anomalies. Specific areas of focus should include individual level exposure methods and improved knowledge on the mechanism of action of air pollutants with regards to teratogenic effects on the developing embryo and fetus. Public health efforts should continue to highlight the importance of minimizing population-level exposure to harmful PM in the air. Although the increased risk of birth defects observed in our study with PM2.5 exposure in the month before conception is modest, the potential impact on a population basis is noteworthy as all reproductive age women have some degree of exposure. ■
Atypical Exanthem after Exposure to Natural Measles: Eleven Cases in Children Previously Inoculated with Killed Vaccine
Nader PR, Horwitz MS, Rousseau R. J Pediatr 1968;72:22-8 N ader et al reported a series of 5 children who had "atypical measles," adding to a growing number of publications describing this condition. The patients included by Nader et al manifested high fever and myalgias, followed by a macular or vesicular rash; 2 had respiratory symptoms. All had been immunized previously with killed measles vaccine, and 4 of the 5 patients had antimeasles antibody titers of >1:1000, well above that measured during typical measles.
Both killed and live attenuated measles vaccines were introduced in 1963. Many clinicians initially favored the former, because the early live vaccine was associated with an intense febrile reaction. In the ensuing years, however, it became apparent that children who received the killed vaccine frequently had short-lived antibody responses and poor protection against wild-type infection. Consequently, the killed vaccine was withdrawn from the market in 1968. The first cases of atypical measles among recipients of the killed vaccine were described in 1965 in a prospectively followed cohort. It is a testament to the clinical acumen of these early investigators that the connection to the killed measles vaccine was made at all, because the atypical form had little in common with typical measles: there was no coryza, no conjunctivitis, no Koplik spots, and the rash was discrete and progressed centripetally rather than the characteristic measles rash that was confluent and extended from the face downward. The inability to isolate virus from patients with atypical measles and the exaggerated antibody response supported the contention that the entity represented an immune reaction primed by the killed vaccine and then triggered by exposure to wild-type measles as the vaccine-associated immunity was waning.
As the experience with killed vaccine faded into history, so did atypical measles, and the condition truly may be one of historic interest only. Or is it? Occasional cases have been described in children immunized only with the live attenuated vaccine when exposed to wild-type virus. Because atypical measles, even when severe, characteristically resolves without intervention, one can imagine the rare contemporaneous child presenting with the findings described in Nader et al and attributed to an unidentified virus or rheumatologic disease, and who remains undiagnosed because the tell-tale measles titers are never drawn. Tables II, III , and IV and Figure 1 . †P values were calculated using the c 2 test for each factor (contingency table) . For comparisons where the c 2 test was not appropriate, the Fisher exact test was used. Statistically significant results with lower bound of 95% confidence interval >1.0 are indicated in bold. *For cases of individual congenital anomalies, births with a chromosome disorder in addition to the congenital anomaly were not included in this analysis. †Hypospadias analysis was limited to male infants, and the infant sex covariate was excluded from the adjusted model. ‡Abdominal defect models did not include prepregnancy diabetes owing to a lack of observations of that covariate in the outcome group. §Neural tube defects and hypospadias models did not include maternal race owing to a lack of observations in one race category within the outcome group. 
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